Who Should Consider PGT-A? Understanding Benefits, Limitations, and Cumulative Outcomes

Key Takeaways

• PGT-A screens IVF embryos for chromosome number changes; it does not improve an embryo’s quality.
• Some couples may avoid unsuccessful transfers, but testing does not guarantee pregnancy or a healthy baby.
• A reassuring result per transfer does not necessarily mean more babies born per egg retrieval.
• Your age, embryo numbers, history and preferences should guide a discussion with your doctor.

If you are comparing PGT A benefits risks, you probably want a straightforward answer: will testing help us have a baby, or add another procedure? The answer depends on your situation, especially how many embryos you have and what you hope testing will achieve.

Who Should Consider PGT-A? Understanding Benefits, Limitations, and Cumulative Outcomes

At a fertility consultation, an optional test can feel like something you must accept. You do not have to decide immediately. Ask what the test could change in your treatment and what happens if no embryo receives a clear result.

What does PGT-A actually test?

PGT-A means preimplantation genetic testing for aneuploidy. It checks a small sample of cells from an IVF embryo for missing or extra chromosomes. These changes can prevent implantation or contribute to miscarriage.

Testing usually happens when an embryo reaches the blastocyst stage. An embryologist removes a few cells from the outer layer, which mainly contributes to the placenta. The embryo is generally frozen while the sample is analysed.

A result may be euploid, meaning the expected chromosome number, or aneuploid, meaning an abnormal number. Sometimes it is mosaic, suggesting a mixture of cells, or inconclusive. The sample cannot describe every cell in the embryo with certainty.

PGT-A does not test for every inherited condition or birth defect. PGT-M and PGT-SR are different tests used for particular genetic conditions or chromosome rearrangements.

PGT A benefits risks: who may consider testing?

Routine PGT-A for every IVF patient is not supported by current evidence. A doctor will decide whether to recommend it after reviewing your records, while the decision to proceed should include your informed preferences.

When eggs are from an older age group

Chromosome number changes become more common as egg age increases. Testing may help select an embryo for transfer when several blastocysts are available. With frozen eggs, age at egg collection matters more than age at transfer.

Age alone is not enough to make the decision. Someone expecting very few embryos faces a different calculation from someone with several available for testing.

After pregnancy losses or unsuccessful transfers

PGT-A may be discussed after repeated miscarriages or failed transfers, but it is not a proven answer for everyone in these groups. Other causes need assessment, and testing cannot fix uterine factors or all causes of pregnancy loss.

• Several available blastocysts: testing may help decide the order of transfer.
• A previous chromosome-related loss: genetic counselling can clarify whether PGT-A or another test is relevant.
• Repeated unsuccessful treatment: review the full history before assuming chromosomes explain it.
• A strong wish to reduce unsuccessful transfers: discuss this alongside cost, delay and uncertain overall benefit.

If a parent carries a chromosome rearrangement, a genetics specialist may recommend PGT-SR rather than PGT-A alone. These tests are not interchangeable.

What benefits are realistic?

For selected patients, transferring an embryo reported as euploid may reduce transfers of embryos unlikely to develop into a pregnancy. It may also reduce chromosome-related miscarriage, although it cannot remove miscarriage risk.

Some couples may need fewer transfers to reach a pregnancy. Others may spend longer waiting because biopsy, testing and a later frozen transfer add steps. A shorter time to a baby is not guaranteed.

PGT-A selects among available embryos. It does not create more embryos or repair abnormal chromosomes. This distinction matters when you hear that testing “improves IVF success”.

Why cumulative outcomes matter more than one transfer

A success figure per embryo transfer only describes transfers that actually happened. It can leave out people who had no blastocyst to test or no embryo considered suitable for transfer after testing.

Cumulative live birth looks at whether a live birth occurs across transfers using embryos from one egg retrieval, within a defined follow-up period. Ask which patients and transfers are included whenever this outcome is quoted.

Measure	What it tells you	What to ask
Live birth per transfer	Outcome after an embryo is transferred	Are patients with no transfer excluded?
Cumulative live birth per retrieval	Outcome across transfers from one egg collection	Are all retrievals included, and how long is follow-up?
Miscarriage rate	Pregnancy losses within a defined group	Is this measured per pregnancy or per treatment cycle?
Time to live birth	How long treatment takes to result in a baby	Does it include testing and waiting periods?

Suppose you have two blastocysts. Testing might help choose which to transfer first. But if both could eventually have been transferred without testing, better selection for the first transfer does not automatically increase your overall chance of a baby.

That is why a useful discussion of PGT A benefits risks includes cumulative outcomes, not just the result after transferring a selected embryo.

Limitations to discuss before giving consent

• Sampling uncertainty: a few outer cells may not fully represent the embryo.
• Mosaic findings: some mosaic embryos can result in healthy births; specialist counselling is needed.
• Unclear results: repeat biopsy may be offered, bringing extra handling and uncertainty.
• Procedure risks: biopsy and freezing involve a small risk of damage or loss.
• No transfer: testing may leave no embryo recommended for transfer.
• Additional expense: request a written breakdown of biopsy, testing, freezing, storage and transfer charges.

Laboratory methods and policies for reporting mosaicism differ. Ask how embryos with uncertain results are reviewed before making irreversible decisions about storage or disposal.

Questions to carry to your Delhi consultation

Before adding testing to IVF treatment in Lajpat Nagar, take your previous cycle summaries, embryology reports and any pregnancy-loss genetic reports. These are more useful than comparing another couple’s treatment plan.

• What benefit do you expect in my specific case?
• How would the advice change if I have only one blastocyst?
• What is your policy for mosaic or inconclusive results?
• Could testing improve transfer selection without improving cumulative live birth?
• Can we discuss the option of transferring without PGT-A?

Pravi Global IVF is at E-3, 3rd Floor, Lajpat Nagar 2, New Delhi. Couples from across Delhi NCR often use the Metro; Lajpat Nagar station is on the Violet and Pink lines. Others come by cab or car, depending on traffic.

Allow some flexibility around office hours and Lajpat Nagar market traffic. Confirm appointment details through the clinic contact page, and ask whether both partners should attend the counselling visit.

Frequently Asked Questions

Is PGT-A necessary for every IVF cycle?

No. Your doctor will assess whether it is worth recommending. Younger egg age, few embryos or other treatment priorities may make routine testing less useful.

Does a euploid result guarantee a baby?

No. Implantation and pregnancy depend on several factors. A euploid result does not exclude every genetic condition, birth defect or cause of miscarriage.

Can a mosaic embryo be transferred?

Sometimes. The finding needs review with a genetics specialist and your fertility doctor. Potential outcomes, alternatives and prenatal diagnostic options should be discussed before transfer.

Is prenatal testing still needed after PGT-A?

Prenatal screening and diagnostic options should still be offered. PGT-A does not replace pregnancy care or diagnostic tests such as CVS or amniocentesis when appropriate.

What if I have only one embryo?

Review PGT A benefits risks carefully with your doctor. There is no transfer order to choose, although testing might inform whether to transfer. Uncertainty and the possibility of no transfer deserve particular attention.

For an individual discussion at Pravi Global IVF, call +91 80091 50040 or book an appointment. Bring your reports so the advice reflects your own treatment options.